The XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) will be organised by the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry, on behalf of the European Federation for Medicinal Chemistry (EFMC).
The EFMC is the main organisation for European Medicinal Chemistry community, with 25 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in its field and attracts traditionally around 1200 participants, from industry and academia. Recent EFMC-ISMC meetings have taken place in Austria (Vienna, 2008), Belgium (Brussels, 2010), Germany (Berlin, 2012) and most recently in Portugal (Lisbon, 2014).
The 2016 edition will continue the tradition of covering recent progress in drug research in major therapeutic areas, including the treatment of pain, CNS disorders, infections, cardiovascular diseases and cancer. EFMC-ISMC 2016 will present the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. The impact of biomarkers and imaging at the interfaces between chemistry, biology and experimental medicine will be illustrated. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of novel organic synthesis in drug discovery.
The symposium will take place at the Manchester Central Convention Complex from August 28 - September 1, 2016.
.jpg "EFMC-ISMC 2016")
